Park Ha Biological Technology (BYAH) Receivables - Other (2023 - 2026)

Park Ha Biological Technology (BYAH) has reported Receivables - Other for 4 consecutive years, with $118255.0 the latest figure, recorded in Q2 2026.

• Quarterly Receivables - Other rose 134.73% year-over-year to $118255.0 in Q2 2026, while the trailing twelve-month figure through Apr 2026 was $118255.0 (up 134.73% YoY) and the FY2025 annual result came in at $363628.0, up 423.55% from the prior year.
• Receivables - Other declined to $118255.0 in Q2 2026 per BYAH's latest filing, from $363628.0 in the prior quarter.
• Over the last five years, Receivables - Other for BYAH reached as high as $363628.0 in Q4 2025 and fell as low as $10964.0 in Q4 2023.
• A 4-year average of $122536.2 and a median of $69454.0 in 2024 frame the typical range for Receivables - Other.
• Annual changes were most pronounced in 2024 — Receivables - Other jumped 533.47% — and 2026, when it soared 134.73%.
• Year by year, Receivables - Other stood at $10964.0 in 2023, then soared by 533.47% to $69454.0 in 2024, then soared by 423.55% to $363628.0 in 2025, then sank by 67.48% to $118255.0 in 2026.
• According to Business Quant data, Receivables - Other over the past three periods registered $118255.0, $363628.0, and $50380.0 for Q2 2026, Q4 2025, and Q2 2025 respectively.